What is the value of assessing inflammation in assessing stroke risk?
The value of assessing inflammation in assessing risk to optimize the primary prevention of stroke is controversial. Several studies suggest a relationship between hs-CRP and lipoprotein-associated phospholipase A2 and stroke risk, with RRs between the highest tertiles/quartiles and the lowest tertile/quartile ranging from 1.5 to 2.0. However, hs-CRP is also associated with similar increases in mortality from several cancers and lung diseases, indicating that its association with cardiovascular risk is not specific.